Mechanistically, several studies have shown that MELLT3 and METTL14 serve an oncogenic role in AML by promoting the translation of MYC, MYB, BCL2, SP1 and PTEN, thus increasing the levels of phospho-AKT [41, 42]. The gene discussed is MYC; the disease is acute myeloid leukemia.